Biohaven shares rose 32.60% after the US Food and Drug Administration accepted the company's reapplication for brain disease drugs.

Zhitongcaijing · 2d ago
Biohaven shares rose 32.60% after the US Food and Drug Administration accepted the company's reapplication for brain disease drugs.